136 related articles for article (PubMed ID: 20439528)
1. Association of RNA polymerase III antibodies with scleroderma renal crisis.
Nguyen B; Assassi S; Arnett FC; Mayes MD
J Rheumatol; 2010 May; 37(5):1068; author reply 1069. PubMed ID: 20439528
[No Abstract] [Full Text] [Related]
2. Anti-RNA polymerase III antibodies are associated with scleroderma renal crisis in a French cohort.
Emilie S; Goulvestre C; Bérezné A; Pagnoux C; Guillevin L; Mouthon L
Scand J Rheumatol; 2011; 40(5):404-6. PubMed ID: 21623662
[No Abstract] [Full Text] [Related]
3. Anti-RNA polymerase III antibodies in the diagnosis of scleroderma renal crisis sine scleroderma.
Phan TG; Cass A; Gillin A; Trew P; Fertig N; Sturgess A
J Rheumatol; 1999 Nov; 26(11):2489-92. PubMed ID: 10555916
[TBL] [Abstract][Full Text] [Related]
4. A case of renal crisis in a Korean scleroderma patient with anti-RNA polymerase I and III antibodies.
Kang EH; Im CH; Kim SH; Chung JR; Lee EY; Kim DJ; Lee EB; Song YW
J Korean Med Sci; 2006 Dec; 21(6):1121-3. PubMed ID: 17179700
[TBL] [Abstract][Full Text] [Related]
5. RNA polymerase III autoantibodies may indicate renal and more severe skin involvement in systemic sclerosis.
Terras S; Hartenstein H; Höxtermann S; Gambichler T; Kreuter A
Int J Dermatol; 2016 Aug; 55(8):882-5. PubMed ID: 26499848
[TBL] [Abstract][Full Text] [Related]
6. Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study.
Meyer O; De Chaisemartin L; Nicaise-Roland P; Cabane J; Tubach F; Dieude P; Hayem G; Palazzo E; Chollet-Martin S; Kahan A; Allanore Y
J Rheumatol; 2010 Jan; 37(1):125-30. PubMed ID: 19918031
[TBL] [Abstract][Full Text] [Related]
7. Serologic profile and mortality rates of scleroderma renal crisis in Italy.
Codullo V; Cavazzana I; Bonino C; Alpini C; Cavagna L; Cozzi F; Del Papa N; Franceschini F; Guiducci S; Morozzi G; Ruffatti A; Ferri C; Giacomelli R; Matucci-Cerinic M; Valentini G; Montecucco C
J Rheumatol; 2009 Jul; 36(7):1464-9. PubMed ID: 19487262
[TBL] [Abstract][Full Text] [Related]
8. Inclusion body myositis in a patient with RNA polymerase III antibody-positive systemic sclerosis.
Vemulapalli S; Sharer LR; Hsu VM
J Rheumatol; 2015 Apr; 42(4):730-2. PubMed ID: 25834244
[No Abstract] [Full Text] [Related]
9. Systemic sclerosis sine scleroderma: an unusual presentation in scleroderma renal crisis.
Molina JF; Anaya JM; Cabrera GE; Hoffman E; Espinoza LR
J Rheumatol; 1995 Mar; 22(3):557-60. PubMed ID: 7783082
[TBL] [Abstract][Full Text] [Related]
10. Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies.
Hamaguchi Y; Kodera M; Matsushita T; Hasegawa M; Inaba Y; Usuda T; Kuwana M; Takehara K; Fujimoto M
Arthritis Rheumatol; 2015 Apr; 67(4):1045-52. PubMed ID: 25512203
[TBL] [Abstract][Full Text] [Related]
11. Anti-RNA polymerase III antibody positive limited cutaneous systemic sclerosis with cryoglobulin-induced digital gangrene.
Deguchi A; Yamaoka T; Komurasaki Y; Hayashi M; Kiyohara E; Murota H; Katayama I
Clin Exp Dermatol; 2017 Mar; 42(2):200-201. PubMed ID: 27739106
[No Abstract] [Full Text] [Related]
12. Disappearance of circulating autoantibodies to RNA polymerase III in a patient with systemic sclerosis successfully treated with corticosteroid and methotrexate.
Tanahashi K; Sugiura K; Muro Y; Akiyama M
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1453-4. PubMed ID: 24916000
[No Abstract] [Full Text] [Related]
13. Scleroderma renal crisis in a Swedish systemic sclerosis cohort: survival, renal outcome, and RNA polymerase III antibodies as a risk factor.
Hesselstrand R; Scheja A; Wuttge DM
Scand J Rheumatol; 2012 Feb; 41(1):39-43. PubMed ID: 22044051
[TBL] [Abstract][Full Text] [Related]
14. Anti-RNA polymerase III antibody-associated scleroderma renal crisis in a patient with limited cutaneous systemic sclerosis: A case report.
Takada D; Hoshino J; Kikuchi K; Yabuuchi J; Kogure Y; Ueno T; Sekine A; Yamanouchi M; Sumida K; Mise K; Suwabe T; Hayami N; Sawa N; Takaichi K; Hayasi N; Fujii T; Ohashi K; Ubara Y
Mod Rheumatol; 2018 Mar; 28(2):369-372. PubMed ID: 26942857
[TBL] [Abstract][Full Text] [Related]
15. Anti-RNA polymerase III antibodies as a risk marker for early gastric antral vascular ectasia (GAVE) in systemic sclerosis.
Ceribelli A; Cavazzana I; Airò P; Franceschini F
J Rheumatol; 2010 Jul; 37(7):1544. PubMed ID: 20595295
[No Abstract] [Full Text] [Related]
16. Protective Effect Against Cancer of Antibodies to the Large Subunits of Both RNA Polymerases I and III in Scleroderma.
Shah AA; Laiho M; Rosen A; Casciola-Rosen L
Arthritis Rheumatol; 2019 Sep; 71(9):1571-1579. PubMed ID: 30888702
[TBL] [Abstract][Full Text] [Related]
17. Anti-RNA Polymerase II Antibodies in a U.S. Cohort of Systemic Sclerosis Patients: Comment on the Article by Hamaguchi et al.
Patel V; Assassi S; Mayes MD; Feghali-Bostwick CA
Arthritis Rheumatol; 2015 Sep; 67(9):2547-8. PubMed ID: 25988706
[No Abstract] [Full Text] [Related]
18. [Cancers associated with systemic sclerosis involving anti-RNA polymerase III antibodies].
Monfort JB; Mathian A; Amoura Z; Francès C; Barbaud A; Senet P
Ann Dermatol Venereol; 2018 Jan; 145(1):33-36. PubMed ID: 28917576
[TBL] [Abstract][Full Text] [Related]
19. Diffuse alveolar haemorrhage in a case with anti-RNA polymerase III antibody-positive systemic sclerosis successfully treated with plasma exchange and corticosteroid therapy.
Asai A; Banno S; Asai N; Ito M; Sugiyama H; Yamaguchi M; Iwagaitsu S; Nobata H; Kinasi H; Katsuno T; Ito Y
Mod Rheumatol Case Rep; 2020 Jan; 4(1):51-55. PubMed ID: 33086969
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Future Scleroderma Renal Crisis at Systemic Sclerosis Diagnosis.
Gordon SM; Stitt RS; Nee R; Bailey WT; Little DJ; Knight KR; Hughes JB; Edison JD; Olson SW
J Rheumatol; 2019 Jan; 46(1):85-92. PubMed ID: 30008456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
